1. Home
  2. TRVI vs HTBK Comparison

TRVI vs HTBK Comparison

Compare TRVI & HTBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • HTBK
  • Stock Information
  • Founded
  • TRVI 2011
  • HTBK 1997
  • Country
  • TRVI United States
  • HTBK United States
  • Employees
  • TRVI N/A
  • HTBK N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • HTBK Major Banks
  • Sector
  • TRVI Health Care
  • HTBK Finance
  • Exchange
  • TRVI Nasdaq
  • HTBK Nasdaq
  • Market Cap
  • TRVI 725.7M
  • HTBK 588.2M
  • IPO Year
  • TRVI 2019
  • HTBK 1998
  • Fundamental
  • Price
  • TRVI $6.89
  • HTBK $10.29
  • Analyst Decision
  • TRVI Strong Buy
  • HTBK Buy
  • Analyst Count
  • TRVI 9
  • HTBK 3
  • Target Price
  • TRVI $19.94
  • HTBK $11.33
  • AVG Volume (30 Days)
  • TRVI 1.6M
  • HTBK 481.2K
  • Earning Date
  • TRVI 08-07-2025
  • HTBK 07-24-2025
  • Dividend Yield
  • TRVI N/A
  • HTBK 4.99%
  • EPS Growth
  • TRVI N/A
  • HTBK N/A
  • EPS
  • TRVI N/A
  • HTBK 0.68
  • Revenue
  • TRVI N/A
  • HTBK $174,083,000.00
  • Revenue This Year
  • TRVI N/A
  • HTBK $7.71
  • Revenue Next Year
  • TRVI N/A
  • HTBK $6.13
  • P/E Ratio
  • TRVI N/A
  • HTBK $15.32
  • Revenue Growth
  • TRVI N/A
  • HTBK N/A
  • 52 Week Low
  • TRVI $2.36
  • HTBK $8.09
  • 52 Week High
  • TRVI $7.48
  • HTBK $11.27
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 64.54
  • HTBK 65.39
  • Support Level
  • TRVI $5.41
  • HTBK $10.34
  • Resistance Level
  • TRVI $6.08
  • HTBK $10.52
  • Average True Range (ATR)
  • TRVI 0.32
  • HTBK 0.21
  • MACD
  • TRVI 0.14
  • HTBK 0.02
  • Stochastic Oscillator
  • TRVI 89.91
  • HTBK 71.19

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

Share on Social Networks: